Medexus
1 known investors
Medexus Pharmaceuticals is an orphan drug and rare disease pharmaceutical company with integrated commercial operations, supply chain, regulatory, and medical affairs infrastructure serving the North American market.
Biotech
Investors · 1
In the news
- Earnings call transcript: Medexus posts stronger Q4 2026 cash flow, stock slips By Investing.cominvesting.com · 2026
- What is Brief History of Medexus Pharma Company? – MatrixBCG.commatrixbcg.com · 2025